François, Bruno
Jafri, Hasan S.
Bonten, Marc
Article History
Received: 18 February 2016
Accepted: 21 March 2016
First Online: 31 March 2016
Compliance with ethical standards
:
: Bruno Francois is the coordinating principal investigator of an ongoing international phase II trial testing a monoclonal antibody against <i>S. aureus</i> to prevent VAP in ICU patients in collaboration with Medimmune, a member of the AstraZeneca group. No other conflict of interest related to this manuscript to declare. Hasan Jafri is an employee of MedImmune, AstraZeneca, the manufacturer of anti-infectious disease monoclonal antibodies. He is currently leading the development and conduct of studies focused on prevention of nosocomial pneumonia, using monoclonal antibodies targeting <i>S. aureus</i> and <i>P. aeruginosa</i>. No other conflict of interest related to this manuscript to declare. Marc Bonten is a member of the study team of an ongoing international phase II trial testing a monoclonal antibody against <i>S. aureus</i> to prevent VAP in ICU patients in collaboration with Medimmune, a member of the AstraZeneca group, as part of the IMI-funded COMBACTE and COMBACTE MAGNET projects. No other conflict of interest related to this manuscript to declare.
Free to read: This content has been made available to all.